In the wake of September 11th, the nation's bioterrorism response capability has become a priority. In a workshop, convened by the Institute of Medicine's Forum on Emerging Infections, experts came together to identify, clarify, and prioritize the next steps that need to be taken to prepare and strengthen bioterrorism response capabilities.

1 Front Matter; 2 Summary and Assessment; 3 1 Introduction; 4 2 Assessing Our Understanding of the Threats; 5 3 Vaccines: Research, Development, Production, and Procurement Issues; 6 4 The Research Agenda: Implications for Therapeutic Countermeasures to Biological Threats; 7 5 Assessing the Capacity of the Public Health Infrastructure; 8 6 Scientific and Policy Tools for Countering Bioterrorism; 9 Appendix A: Agenda: Biological Threats and Terrorism: How Preparted Are We?; 10 Appendix B: Information Resources; 11 Appendix C: Testimony of Joshua Lederberg, Ph.D; 12 Appendix D: Summary of the Frist-Kennedy; 13 Appendix E: Department of Health and Human Services: Food and Drug Administration; 14 Appendix F: Veterans Affairs/Department of Defense Contingency; 15 Appendix G: The Model State Emergency Health Powers Act; 16 Appendix H: NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness; 17 Appendix I: Statement on Vaccine Development; 18 Appendix J: Testimony of Kenneth Shine, M.D; 19 Appendix K: Glossary and Acronyms; 20 Appendix L: Forum Member, Speaker, and Staff Biographies